Literature DB >> 3558818

In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects.

H J Harwood, D M Bridge, P W Stacpoole.   

Abstract

In vivo regulation of microsomal HMG CoA reductase activity was investigated in freshly isolated mononuclear leukocytes from 26 healthy adult males. Reductase activity exhibited a diurnal rhythm and decreased during fasting. Enzyme activity was also modulated in vivo by alterations in dietary and plasma cholesterol, suggesting the existence of an operative cholesterol feedback regulatory system. A single, high cholesterol meal decreased reductase activity within 2 h. In addition, rapid depletion of circulating cholesterol levels by plasmapheresis led to an approximately twofold elevation in enzyme activity within 90 min of treatment. Finally, reductase activity was inhibited by dichloroacetate, a compound known to lower plasma cholesterol in man and inhibit the human leukocyte enzyme in vitro. The regulatory mechanisms controlling HMG CoA reductase activity in the human mononuclear leukocyte in vivo thus are similar to those that modulate the mammalian liver enzyme in vivo. Assessment of mononuclear leukocyte reductase activity may provide insight into the in vivo regulation of human cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558818      PMCID: PMC424293          DOI: 10.1172/JCI112928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Cholesterol metabolism in anorexia nervosa and hypercholesterolemia.

Authors:  P J Nestel
Journal:  J Clin Endocrinol Metab       Date:  1974-02       Impact factor: 5.958

2.  Fine structure of the cyclic rhythm of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Differential effects of cholesterol feeding and fasting.

Authors:  D J Shapiro; V W Rodwell
Journal:  Biochemistry       Date:  1972-03-14       Impact factor: 3.162

3.  Diurnal variation of HMG CoA reductase activity in rat intestine.

Authors:  S Shefer; S Hauser; V Lapar; E H Mosbach
Journal:  J Lipid Res       Date:  1972-09       Impact factor: 5.922

4.  The key role of nutritional factors in the prevention of coronary heart disease.

Authors:  W E Connor; S L Connor
Journal:  Prev Med       Date:  1972-03       Impact factor: 4.018

5.  Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia.

Authors:  A M Fogelman; J Edmond; J Seager; G Popják
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

6.  Effects of dietary cholesterol on the regulation of total body cholesterol in man.

Authors:  E Quintão; S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

7.  Diurnal changes in the fraction of 3-hydroxy-3-methylglutaryl-CoA reductase in the active form in rat liver microsomal fractions.

Authors:  R A Easom; V A Zammit
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

8.  Improved estimation of body masses and turnover of cholesterol by computerized input--output analysis.

Authors:  P Samuel; S Lieberman
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

9.  Three-pool model of the long-term turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

10.  Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods.

Authors:  S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1969-01       Impact factor: 5.922

View more
  8 in total

1.  In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia.

Authors:  P W Stacpoole; D M Bridge; I M Alvarez; R B Goldberg; H J Harwood
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Circadian variations in rat liver gene expression: relationships to drug actions.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Debra C DuBois; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2008-06-18       Impact factor: 4.030

3.  Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.

Authors:  P Boucher; M de Lorgeril; P Salen; P Crozier; J Delaye; J J Vallon; A Geyssant; R Dante
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

4.  Erythrocyte contamination of leukocyte populations following density-gradient centrifugation results in artificially high levels of human leukocyte HMG-CoA reductase activity.

Authors:  H J Harwood; D M Bridge; P W Stacpoole
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

Review 5.  Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.

Authors:  Siddharth Sukumaran; Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Adv Drug Deliv Rev       Date:  2010-06-11       Impact factor: 15.470

6.  Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.

Authors:  E E Powell; P A Kroon
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 7.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

8.  Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men.

Authors:  B G Stone; T J Besse; W C Duane; C D Evans; E G DeMaster
Journal:  Lipids       Date:  1993-08       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.